L A Ambroso - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

L A Ambroso

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancer Biochemistry Biophysics|September 1, 1993

Expression of a 118 Kd protein in colon carcinoma cells that is immunologically related to PLC-gamma 1 and is augmented by serum-free conditionsD W Fry, L A Ambroso

Nucleic Acids Research|December 11, 1992

Structure and evolution of the XcyI restriction-modification systemB E Withers, L A Ambroso, J C Dunbar

Science (New York, N.Y.)|August 19, 1994

A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseD W Fry, A J Kraker, A McMichael, et al.

Journal of Medicinal Chemistry|February 14, 1997

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancer Biochemistry Biophysics|September 1, 1993

Expression of a 118 Kd protein in colon carcinoma cells that is immunologically related to PLC-gamma 1 and is augmented by serum-free conditionsD W Fry, L A Ambroso

Nucleic Acids Research|December 11, 1992

Structure and evolution of the XcyI restriction-modification systemB E Withers, L A Ambroso, J C Dunbar

Science (New York, N.Y.)|August 19, 1994

A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseD W Fry, A J Kraker, A McMichael, et al.

Journal of Medicinal Chemistry|February 14, 1997

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.

Pageof 1